Orient Pharma Co

Orient Pharma Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Orient Pharma Co (4166.TWO) as of Oct 27, 2026 is 267.06 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 173.91 M TWD — a change of 53.56% (higher).

EBITDA

267.06 MTWD

YoY

53.56%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Orient Pharma Co is 2025 267.06 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Orient Pharma Co was 2024 173.91 M TWD. It decreases by 53.56% higher compared to the previous year.

The Orient Pharma Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-249.06 M TWD
Jan 1, 2019
-205.37 M TWD
Jan 1, 2020
-160.68 M TWD
Jan 1, 2021
-104.91 M TWD
Jan 1, 2022
-34.82 M TWD
Jan 1, 2023
40.26 M TWD
Jan 1, 2024
173.91 M TWD
Jan 1, 2025
267.06 M TWD
The Orient Pharma Co EBITDA history
YEAREBITDAYoY
267.06 MTWD+53.56%
173.91 MTWD+331.98%
40.26 MTWD-215.61%
-34.82 MTWD-66.81%
-104.91 MTWD-34.71%
-160.68 MTWD-21.76%
-205.37 MTWD-17.54%
-249.06 MTWD-19.33%
-308.73 MTWD+34.82%
-228.99 MTWD-9.58%
-253.26 MTWD+45.28%
-174.32 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Orient Pharma Co Stock analysis

What does Orient Pharma Co do? Orient Pharma Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orient Pharma Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Orient Pharma Co is 267.06 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Orient Pharma Co changed from 173.91 M TWD to 267.06 M TWD, representing a 53.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Orient Pharma Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Orient Pharma Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Orient Pharma Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Orient Pharma Co